Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation

Summary: Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease mediated by the interplay of T cells and polymorphonuclear granulocytes. Although preclinical studies have provided insights into the mechanisms of disease initiation, the underpinnings of natural dise...

Full description

Bibliographic Details
Main Authors: Tom Hartwig, Pascale Zwicky, Bettina Schreiner, Nikhil Yawalkar, Phil Cheng, Alexander Navarini, Reinhard Dummer, Lukas Flatz, Curdin Conrad, Christoph Schlapbach, Burkhard Becher
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124718319235
_version_ 1818939583804473344
author Tom Hartwig
Pascale Zwicky
Bettina Schreiner
Nikhil Yawalkar
Phil Cheng
Alexander Navarini
Reinhard Dummer
Lukas Flatz
Curdin Conrad
Christoph Schlapbach
Burkhard Becher
author_facet Tom Hartwig
Pascale Zwicky
Bettina Schreiner
Nikhil Yawalkar
Phil Cheng
Alexander Navarini
Reinhard Dummer
Lukas Flatz
Curdin Conrad
Christoph Schlapbach
Burkhard Becher
author_sort Tom Hartwig
collection DOAJ
description Summary: Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease mediated by the interplay of T cells and polymorphonuclear granulocytes. Although preclinical studies have provided insights into the mechanisms of disease initiation, the underpinnings of natural disease remission remain largely unknown. Here, we addressed the contribution of regulatory Foxp3+ T cells (Treg cells) in psoriasiform skin inflammation and remission using the Aldara-skin inflammation model in combination with the inducible depletion of Foxp3+ Treg cells. Loss of Treg cells exacerbated skin inflammation, but this did not involve increased γδ T cell expansion or the local production of the psoriasis-associated cytokines IL-17A, IL-17F, and IL-22, which are the main driving forces of disease development. Instead, Treg cells suppressed the infiltration of granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing CD4+ T cells into the lesioned skin, and neutralizing GM-CSF in Treg cell-deficient mice reversed hyper-inflammation, resulting in disease regression. Therefore, we identified a non-redundant role of Treg cells restraining skin inflammation and mediating skin homeostasis. : The contribution of Treg cells to psoriasis is poorly understood. By combining inducible depletion of Treg cells with the Aldara model of psoriasiform inflammation, Hartwig et al. reveal a non-redundant role of Treg cells in promoting the remission of skin inflammation by limiting invasion of CD4+ GM-CSF-producing T cells into psoriatic skin. Keywords: psoriasis, melanoma, ipilimumab, Aldara, skin inflammation, Foxp3, Treg cells, CD4 T cells, GM-CSF
first_indexed 2024-12-20T06:26:04Z
format Article
id doaj.art-8d9c187b76344a6880e7889d53095cd4
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-20T06:26:04Z
publishDate 2018-12-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-8d9c187b76344a6880e7889d53095cd42022-12-21T19:50:17ZengElsevierCell Reports2211-12472018-12-01251335643572.e4Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin InflammationTom Hartwig0Pascale Zwicky1Bettina Schreiner2Nikhil Yawalkar3Phil Cheng4Alexander Navarini5Reinhard Dummer6Lukas Flatz7Curdin Conrad8Christoph Schlapbach9Burkhard Becher10Institute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, SwitzerlandInstitute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, SwitzerlandInstitute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland; Department of Neurology, University Hospital Zurich, 8091 Zurich, SwitzerlandDepartment of Dermatology, Inselspital, University of Bern, 3010 Bern, SwitzerlandDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, SwitzerlandDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, SwitzerlandDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, SwitzerlandDepartment of Dermatology and Allergology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandDepartment of Dermatology, University Hospital CHUV, Lausanne 1011, SwitzerlandDepartment of Dermatology, Inselspital, University of Bern, 3010 Bern, SwitzerlandInstitute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland; Corresponding authorSummary: Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease mediated by the interplay of T cells and polymorphonuclear granulocytes. Although preclinical studies have provided insights into the mechanisms of disease initiation, the underpinnings of natural disease remission remain largely unknown. Here, we addressed the contribution of regulatory Foxp3+ T cells (Treg cells) in psoriasiform skin inflammation and remission using the Aldara-skin inflammation model in combination with the inducible depletion of Foxp3+ Treg cells. Loss of Treg cells exacerbated skin inflammation, but this did not involve increased γδ T cell expansion or the local production of the psoriasis-associated cytokines IL-17A, IL-17F, and IL-22, which are the main driving forces of disease development. Instead, Treg cells suppressed the infiltration of granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing CD4+ T cells into the lesioned skin, and neutralizing GM-CSF in Treg cell-deficient mice reversed hyper-inflammation, resulting in disease regression. Therefore, we identified a non-redundant role of Treg cells restraining skin inflammation and mediating skin homeostasis. : The contribution of Treg cells to psoriasis is poorly understood. By combining inducible depletion of Treg cells with the Aldara model of psoriasiform inflammation, Hartwig et al. reveal a non-redundant role of Treg cells in promoting the remission of skin inflammation by limiting invasion of CD4+ GM-CSF-producing T cells into psoriatic skin. Keywords: psoriasis, melanoma, ipilimumab, Aldara, skin inflammation, Foxp3, Treg cells, CD4 T cells, GM-CSFhttp://www.sciencedirect.com/science/article/pii/S2211124718319235
spellingShingle Tom Hartwig
Pascale Zwicky
Bettina Schreiner
Nikhil Yawalkar
Phil Cheng
Alexander Navarini
Reinhard Dummer
Lukas Flatz
Curdin Conrad
Christoph Schlapbach
Burkhard Becher
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
Cell Reports
title Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
title_full Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
title_fullStr Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
title_full_unstemmed Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
title_short Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
title_sort regulatory t cells restrain pathogenic t helper cells during skin inflammation
url http://www.sciencedirect.com/science/article/pii/S2211124718319235
work_keys_str_mv AT tomhartwig regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT pascalezwicky regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT bettinaschreiner regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT nikhilyawalkar regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT philcheng regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT alexandernavarini regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT reinharddummer regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT lukasflatz regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT curdinconrad regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT christophschlapbach regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation
AT burkhardbecher regulatorytcellsrestrainpathogenicthelpercellsduringskininflammation